EODData

FRA, AM6: Amicus Therapeutics Inc

30 Dec 2025
LAST:

12.00

CHANGE:
 0.10
OPEN:
12.00
HIGH:
12.00
ASK:
0.00
VOLUME:
40
CHG(%):
0.83
PREV:
12.10
LOW:
12.00
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Dec 2512.0012.0012.0012.0040
29 Dec 2512.1012.1012.1012.101.0K
23 Dec 2512.0012.0012.0012.001.0K
19 Dec 259.209.209.209.201.0K
18 Dec 259.259.259.259.251.0K
17 Dec 259.209.209.209.201.0K
16 Dec 259.109.109.109.101.0K
15 Dec 259.109.109.109.101.0K
12 Dec 258.358.358.358.3550
11 Dec 258.308.308.308.3050

PROFILE

Name:Amicus Therapeutics Inc
About:Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally. The company's commercial product and product candidates consist of Galafold, an orally administered monotherapy for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, a novel two-component treatment program for adults living with late-onset Pompe disease. It has collaboration and license agreement with GlaxoSmithKline to develop and commercialize Galafold. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:47 Hulfish Street, Princeton, NJ, United States, 08542
Website:https://amicusrx.com
ISIN:US03152W1099
LEI:549300MRD1SMUTNBPQ53

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-66.67 
Forward P/E:-23.53 
PEG Ratio:-23.53 
Price to Sales:6.29 
Price to Book:18.95 
Profit Margin:-0.02 
Operating Margin:0.20 
Return on Assets:0.03 
Return on Equity:-0.07 
Revenue:508.02M 
EBITDA:32.73M 
Shares:308.24M 
Market Cap:3.699B 

TECHNICAL INDICATORS

MA5:10.9110.0%
MA10:9.8621.7%
MA20:9.1331.4%
MA50:8.2745.1%
MA100:7.4261.8%
MA200:6.6480.8%
STO9:97.33 
STO14:97.37 
RSI14:94.05 
WPR14:-2.63 
MTM14:3.60
ROC14:0.43 
ATR:0.30 
Week High:12.100.8%
Week Low:12.000.0%
Month High:12.100.8%
Month Low:8.2580.8%
Year High:12.100.8%
Year Low:4.77151.4%
Volatility:2.74